Michael A. Metzger - 09 Feb 2026 Form 4 Insider Report for Syndax Pharmaceuticals Inc (SNDX)

Role
Chief Executive Officer, Director
Signature
/s/ Michael A. Metzger
Issuer symbol
SNDX
Transactions as of
09 Feb 2026
Net transactions value
-$360,819
Form type
4
Filing time
10 Feb 2026, 09:00:18 UTC
Previous filing
06 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Metzger Michael A Chief Executive Officer, Director C/O SYNDAX PHARMACEUTICALS, INC., 730 3RD AVENUE, FLOOR 9, NEW YORK /s/ Michael A. Metzger 10 Feb 2026 0001507220

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNDX Common Stock Sale $360,819 -17,159 -3.4% $21.03 491,690 09 Feb 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units.